Notes et cahiers de recherche


Pour soutenir notre action :
Appuyer l'iem
Partager nos travaux :

Joignez notre groupe sur Facebook

The advantages of incremental pharmaceutical innovation

par Valentin Petkantchin
jeudi 5 avril 2012.

Economic Note

rien

Medical progress from breakthrough drugs - the source of new therapeutic classes - is widely uncontested, but this is far from true of drugs that embody incremental innovations. With pressures for cost containment over health care spending, their innovative character is barely recognised, and their commercialisation is deterred by public authorities, especially in France.

Such policies run counter to the very logic of technological progress, however. They pay little heed to the therapeutic and economic advantages of incremental pharmaceutical innovation. Paradoxically, they raise risks in the pharmaceutical industry and penalise, rather than promote, the development of future revolutionary drugs.

Read the Economic Note…

Read the Media release…



Documents
The advantages of incremental pharmaceutical innovation
Type : PDF (477.7 ko)
Mis à jour le : 4 avril 2012




Institut économique Molinari : proposer des solutions alternatives et  innovantes favorables à la prospérité de l’ensemble des individus composant la  société

Institut économique Molinari
Paris - Bruxelles - Montréal